Tab Application Banner
  • Users Online: 45
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Ixekizumab: an IL-17A inhibitor for the treatment of axial Spondylarthritis
Stephanie R Harrison,Helena Marzo-Ortega
Expert Review of Clinical Immunology.2021;17(10)1059
[DOI]
2Prospective study of patients with inflammatory back pain, clinical characteristics and treatment response in ankylosing spondylitis in two centers of rheumatology in South India
Subramanian Nallasivan,Dhivya Thiyagarajan,Abirami Manivannan
Indian Journal of Rheumatology.2022;17(1)10
[DOI]